eCardio launches extended monitoring device
The eTriggerPLUS is said to be the first generation of extended monitoring devices offered by eCardio. The single component device contains proprietary features such as the eTimer Automatic

The eTriggerPLUS is said to be the first generation of extended monitoring devices offered by eCardio. The single component device contains proprietary features such as the eTimer Automatic

According to the company, the Glucocard system requires no coding, displays results in seven seconds, and requires a tiny 0.3 microliter sample size. Glucocard 01 is AST approved

Guillen was named president and director in April, replacing Phil Passy, MedX’s founder, who passed away earlier in 2008. Prior to joining MedX, Mr Guillen was CEO of

Millipore is seeking LEED certification of the expanded and renovated 17,000-square-foot space, which is just one of Millipore’s three buildings on the 43-acre Missouri Research Park campus. The

Arctic Front, the company’s lead product for the treatment of paroxysmal atrial fibrillation (PAF), is said to be a cryoablation balloon catheter that allows physicians to safely and

A long time director and one of the founders of the company, Mr Chen is expected to guide Welichem Biotech through the next crucial stage of development as

The report also noted that the sales of patented drugs which grew by 27% in 1999 have tumbled down to mere three percent growth in 2007 to C$12.3

The report also noted that the use of the cholesterol-lowerers increased 156% between 2000 and 2005. According to the data released by the Agency for Healthcare Research and

Under the terms of the collaboration, GlaxoSmithKline (GSK) has the right to select up to two of the compounds in the collaboration for further development and commercialization. GSK

Coldizin will be sold under private label as a food supplement, and marketed throughout the country through Negma’s sales and marketing organization. The launch is planned for the